1 |
Beyer, C. E., Lin, Q., Rosenzweig-Lipson, S. and Schechter, L. E. : Alpha 2A-adrenoceptors enhance the serotonergic effects of fluoxetine. Eur. J. Pharmacol. 539, 164 (2006).
DOI
ScienceOn
|
2 |
Blier, P. : Pharmacology of rapid-onset antidepressant treatment strategies. J. Clin. Psychiatry 62 Suppl 15, 12 (2001).
DOI
|
3 |
Pastor, J., Alcazar, J., Alvarez, R. M., Andres, J. I. Cid, J. M., De Lucas, A. I., Diaz, A., Fernandez, J., Font, L. M., Iturrino, L., Lafuente, C., Martinez, S., Bakker, M. H., Biesmans, I., Heylen, L. I. and Megens, A. A. : Synthesis of 3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha2-adrenoceptor antagonistic activities. Part 2: Further exploration on the cinnamyl moiety. Bioorg. Med. Chem. Lett. 14, 2917 (2004).
DOI
ScienceOn
|
4 |
Clark, M. and Cramer, R. : Comparative molecular field analysis (CoMFA). 2. Toward its use with 3D-structural databases. Tetrahedron Computer Methodology 3, 47 (1990).
DOI
|
5 |
Tripos, S. : Molecular modeling and QSAR software on CDRom (Ver. 7.3), Tripos Associates, Inc., 1699 S. Hanley Road, Suite 303, 63144 (2001).
|
6 |
Vasan, A. and Raju, K. : Comparative analysis of Simulated Annealing, Simulated Quenching and Genetic Algorithms for optimal reservoir operation. Applied. Soft. Computing 9, 274 (2009).
DOI
ScienceOn
|
7 |
Soung, M., Lee, Y. and Sung, N. : 3D-QSARs of Herbicidal 2-N-Phenylisoindolin-1-one Analogues as a New Class of Potent Inhibitors of Protox. Bull. Kor. Che. Soc. 30, 613 (2009).
DOI
|
8 |
Marshall, G., Barry, C., Bosshard, H., Dammkoehler, R. and Dunn, D. : The conformational parameter in drug design: the active analog approach. In Computer-assisted Drug Design 112, 205 (1979).
|
9 |
Cramer III, R., Bunce, J., Patterson, D. and Frank, I. : Crossvalidation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct.-Act. Relat. 7, 18 (1988).
DOI
|
10 |
Lindberg, W., Persson, J. and Wold, S. : Partial least-squares method for spectrofluorimetric analysis of mixtures of humic acid and lignin sulfonate. Analytical Chemistry 55, 643 (1983).
DOI
|
11 |
Rang, H., Dale, M., Ritter, J. and Moore, P. : Pharmacology. 5th Edition. Edinburgh, Churchill Livingstone. for Noradrenalin system, p. 186 (2003).
|
12 |
Krogsgaard-Larsen, P., Liljefors, T. and Madsen, U. : Textbook of drug design and discovery. Taylor & Francis, London (2002).
|
13 |
Gumnick, J. F. and Nemeroff, C. B. : Problems with currently available antidepressants. J. Clin. Psychiatry 61 Suppl 10, 5 (2000).
|
14 |
Maze, M. and Tranquilli, W. : Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 74, 581 (1991).
DOI
ScienceOn
|
15 |
Sherman, A., Gal, E. M., Fuller, R. W. and Molloy, B. B. : Effects of intraventricular p-chloroamphetamine and its analogues on cerebral 5-HT. Neuropharmacology 14, 733 (1975).
DOI
ScienceOn
|
16 |
Andres, J. I., Alcazar, J., Alonso, J. M., Alvarez, R. M., Bakker, M. H., Biesmans, I., Cid, J. M., De Lucas, A. I., Fernandez, J., Font, L. M., Hens, K. A., Iturrino, L., Lenaerts, I., Martinez, S., Megens, A. A., Pastor, J., Vermote, P. C. and Steckler, T. : Discovery of a new series of centrally active tricyclic isoxazoles combining serotonin (5-HT) reuptake inhibition with alpha2-adrenoceptor blocking activity. J. Med. Chem. 48, 2054 (2005).
DOI
ScienceOn
|
17 |
Andres, J. I., Alcazar, J., Alonso, J. M., Alvarez, R. M., Cid, J. M., De Lucas, A. I., Fernandez, J., Martinez, S., Nieto, C., Pastor, J., Bakker, M. H., Biesmans, I., Heylen, L. I. and Megens, A. A. : Synthesis of 3a,4-dihydro-3H-[1]benzopyrano [4,3-c]isoxazoles, displaying combined 5-HT uptake inhibiting and alpha(2)-adrenoceptor antagonistic activities: a novel series of potential antidepressants. Bioorg. Med. Chem. Lett. 13, 2719 (2003).
DOI
ScienceOn
|
18 |
Andres, J. I., Alcazar, J., Alonso, J. M., De Lucas, A. I., Iturrino, L., Biesmans, I. and Megens, A. A. : Synthesis of 7-amino-3a,4-dihydro-3H-[1]benzopyrano[4,3-c]isoxazole derivatives displaying combined alpha2-adrenoceptor antagonistic and 5-HT reuptake inhibiting activities. Bioorg. Med. Chem. 14, 4361 (2006).
DOI
ScienceOn
|
19 |
Murthy, R., Bertolote, J., Epping-Jordan, J., Funk, M., Prentice, T., Saraceno, B. and Saxena, S. : The World Health report: 2001: Mental health: new understanding, new hope. World Health Organization, Geneva, Switzerland (2001).
|
20 |
Murray, C. J. and Lopez, A. D. : Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 349, 1498 (1997).
DOI
ScienceOn
|
21 |
이충경, 박강규, 조맹제, 정은기, 김장규, 김선욱 : 2006 정신질환실태 역학조사. 서울: 보건복지부 (2008).
|
22 |
Sanders, A., Detera-Wadleigh, S. and Gershon, E. : Molecular genetics of mood disorders. Neurobiology of Mental Illness. New York, Oxford, 299 (1999).
|
23 |
Akiskal, H. : Mood disorders: introduction and overview. Comprehensive Textbook of Psychiatry. 7th ed. Baltimore, MD: Lippincott Williams and Wilkins, 1284 (2000).
|
24 |
Fava, M. and Kendler, K. S. : Major depressive disorder. Neuron 28, 335 (2000).
DOI
ScienceOn
|
25 |
Hindmarch, I. : Expanding the horizons of depression: beyond the monoamine hypothesis. Hum. Psychopharmacol. 16, 203 (2001).
DOI
ScienceOn
|
26 |
Guze, S. and Robins, E. : Suicide and primary affective disorders. Br. J. Psychiatry 117, 437 (1970).
DOI
ScienceOn
|
27 |
Edwards, J. : Selective serotonin reuptake inhibitors. Br. Med. J. 304, 1644 (1992).
DOI
ScienceOn
|
28 |
The Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). American Psychiatric Association, Washington, DC (2000).
|